ArticleScientific reports2014

The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo.

Hongbo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.